264 related articles for article (PubMed ID: 36127924)
1. Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis.
Klavdianou K; Kanellou A; Daoussis D
Mediterr J Rheumatol; 2022 Mar; 33(Suppl 1):115-125. PubMed ID: 36127924
[TBL] [Abstract][Full Text] [Related]
2. Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
Braun J; Kiltz U; Bühring B; Baraliakos X
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211041854. PubMed ID: 34471428
[TBL] [Abstract][Full Text] [Related]
3. JAK Inhibitors for the Treatment of Axial Spondyloarthritis.
Klavdianou K; Papagoras C; Baraliakos X
Mediterr J Rheumatol; 2023 Jun; 34(2):129-138. PubMed ID: 37654636
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
5. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
[TBL] [Abstract][Full Text] [Related]
6. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
[TBL] [Abstract][Full Text] [Related]
7. No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.
Zhang H; Jiang HL; Dai SM
Front Immunol; 2022; 13():818413. PubMed ID: 35222393
[TBL] [Abstract][Full Text] [Related]
8. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Deodhar A; Strand V; Kay J; Braun J
Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
[TBL] [Abstract][Full Text] [Related]
9. Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis.
Tu L; Lin C; Xie Y; Wang X; Wei Q; Zhang Y; Gu J
Front Immunol; 2021; 12():700260. PubMed ID: 34386008
[TBL] [Abstract][Full Text] [Related]
10. Golimumab for the treatment of axial spondyloarthritis.
Gelfer G; Perry L; Deodhar A
Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
[TBL] [Abstract][Full Text] [Related]
11. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
12. Radiographic progression in non-radiographic axial spondyloarthritis.
Protopopov M; Poddubnyy D
Expert Rev Clin Immunol; 2018 Jun; 14(6):525-533. PubMed ID: 29774755
[TBL] [Abstract][Full Text] [Related]
13. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
14. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
[TBL] [Abstract][Full Text] [Related]
15. The role of ixekizumab in non-radiographic axial spondyloarthritis.
San Koo B; Kim TH
Ther Adv Musculoskelet Dis; 2021; 13():1759720X20986734. PubMed ID: 33488787
[TBL] [Abstract][Full Text] [Related]
16. Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI).
Maguire S; Fitzgerald G; Gallagher P; O'Shea F
Rheumatol Int; 2022 May; 42(5):831-838. PubMed ID: 35088133
[TBL] [Abstract][Full Text] [Related]
17. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
[TBL] [Abstract][Full Text] [Related]
18. The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management.
Magrey MN; Khan MA
Curr Rheumatol Rep; 2017 Apr; 19(4):17. PubMed ID: 28361330
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
